4 free views remaining today
autosomal dominant craniodiaphyseal dysplasia
Description
Autosomal dominant craniometaphyseal dysplasia (CMD) is a rare genetic disorder that affects the bones, particularly in the skull and facial area [9]. It is characterized by progressive thickening and increased mineral density of these bones, leading to various symptoms.
The condition typically involves:
- Thickening of the craniofacial bones, which can cause facial deformities
- Increased bone density, making the bones harder than normal
- Progressive diffuse hyperostosis of cranial bones [1]
- Wide nasal bridge and paranasal bossing [1]
CMD can follow an autosomal dominant pattern of inheritance, meaning that a single copy of the mutated gene is enough to cause the condition [6]. This means that if one parent has the condition, each child has a 50% chance of inheriting it.
It's worth noting that CMD is distinct from craniodiaphyseal dysplasia (CDD), which is another rare bone disorder with similar symptoms but different inheritance patterns [2-5].
References: [1] E Reichenberger · 2020 · Cited by 8 [6] Jun 28, 2019 [9] by E Reichenberger · 2001 · Cited by 217
Additional Characteristics
- Increased bone density
- Thickening of the craniofacial bones
- Progressive diffuse hyperostosis of cranial bones
- Wide nasal bridge and paranasal bossing
Signs and Symptoms
Autosomal dominant craniometaphyseal dysplasia (CMD) is a rare genetic disorder that affects the bones of the skull, face, and other parts of the body. The signs and symptoms of CMD can vary in severity and may include:
- Bone overgrowth: The bones of the head, including the skull, face, and jaw, can become abnormally thickened and enlarged [1].
- Facial features: Individuals with CMD may have distinctive facial features, such as a prominent forehead, wide-set eyes, and a short, broad nose [7].
- Hearing impairment: Hearing loss or impairment is a common symptom of CMD, affecting up to 50% of individuals with the disorder [5].
- Headache: Headaches are another frequent symptom of CMD, caused by increased pressure within the skull [5].
- Increased intracranial pressure: In some cases, CMD can lead to increased pressure within the skull, which can cause symptoms such as headaches, nausea, and vomiting [5].
- Thickened ribs: The ribs may also become abnormally thickened in individuals with CMD [6].
- Short stature: Individuals with CMD often have short stature, which is a result of the abnormal bone growth and development [6].
It's worth noting that the symptoms of CMD can vary widely from person to person, even within the same family. In some cases, the disorder may be mild, while in others it can be more severe.
References: [1] Context 2 [5] Context 5 [6] Context 6 [7] Context 7
Additional Symptoms
- Increased intracranial pressure
- Facial features
- Bone overgrowth
- Hearing impairment
- Thickened ribs
- short stature
- headache
Diagnostic Tests
Autosomal dominant craniodiaphyseal dysplasia (CDD) can be diagnosed through a combination of clinical evaluation and radiographic findings, as well as genetic analysis.
Clinical Evaluation Diagnosis is based on clinical and radiographic findings that include diffuse hyperostosis of the cranial base, cranial vault abnormalities, and other characteristic features [1]. A thorough medical history and physical examination are essential to identify individuals with a personal and/or family history of this disorder, for whom genetic analysis is recommended [2].
Radiographic Findings Imaging tests, such as X-rays, computed tomography (CT) scans, or magnetic resonance imaging (MRI), can help confirm the diagnosis by showing characteristic radiographic features, including diffuse hyperostosis of the cranial base and vault abnormalities [3]. These findings are often accompanied by other skeletal manifestations.
Genetic Analysis Genetic testing is available to provide a molecular diagnosis of autosomal dominant CDD. This is particularly useful for individuals with a family history of the disorder or those who have already been diagnosed with the condition, as it can help identify carriers and confirm the presence of specific mutations [4].
Other Diagnostic Tests While not specifically mentioned in the context provided, other diagnostic tests such as blood tests or molecular genetic testing may also be used to support the diagnosis of autosomal dominant CDD.
References: [1] Context 1 [2] Context 2 [3] Context 5 [4] Context 6
Additional Diagnostic Tests
- Blood tests
- Clinical Evaluation
- Genetic Analysis
- Molecular genetic testing
- Radiographic Findings
Treatment
Based on the available information, it appears that there are limited treatment options for autosomal dominant craniometaphyseal dysplasia (also known as craniodiaphyseal dysplasia). However, some potential treatments have been mentioned in the search results.
- Surgery: Surgical intervention may be necessary to reduce compression of vital structures, such as the airways and digestive tract, which can occur due to the abnormal bone growth associated with this condition [1][3].
- Dental care: Dental care is also an important aspect of managing craniometaphyseal dysplasia, as individuals with this condition may experience dental abnormalities and require specialized dental care [5].
However, it's worth noting that there are no specific drug treatments mentioned in the search results for autosomal dominant craniometaphyseal dysplasia. The only mention of a potential treatment related to bone growth is a reference to drugs being trialed for osteoporosis, which may be relevant due to the mutations in the SOST-gene associated with this condition [6].
It's also important to note that any treatment decisions should be made under the guidance of a qualified medical specialist, as mentioned in search result 4.
References: [1] Search result 1 [3] Search result 3 [5] Search result 5 [6] Search result 6
Recommended Medications
- Surgery
- Dental care
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Based on the provided context, the differential diagnosis for autosomal dominant craniometaphyseal dysplasia (CMD) includes:
- Metaphyseal dysplasia (Pyle disease)
- Craniodiaphyseal dysplasia (CDD)
These conditions are mentioned in search result [4] as major differential diagnoses of CMD.
Additionally, other rare bone disorders that may be considered in the differential diagnosis for autosomal dominant craniometaphyseal dysplasia include:
- Polyostotic fibrous dysplasia
- Osteopetrosis
This information is based on search result [6], which mentions these conditions as part of a differential diagnosis for CMD.
It's worth noting that the differential diagnosis for CMD can be difficult due to its rarity, and many of these conditions are very rare (search result [5]).
Additional Differential Diagnoses
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_3662
- owl#annotatedSource
- t358058
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0080807
- core#notation
- DOID:0080807
- oboInOwl#hasDbXref
- MIM:122860
- IAO_0000115
- A craniodiaphyseal dysplasia that has_material_basis_in heterozygous mutation in the SOST gene on chromosome 17q21.
- rdf-schema#label
- autosomal dominant craniodiaphyseal dysplasia
- rdf-schema#subClassOf
- t357522
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.